DVAX stock is taking a major hit this morning as Dynavax (NASDAQ:DVAX) issued a restructuring plan to focus on its vaccine business.
When it comes to the world of pharmaceuticals, companies often prefer to focus on the drugs that are ready to go into the market rather than those and that is exactly what Dynavax Technologies Corporation have planned to do. However, that is part of the company’s restructuring efforts that they announced a few days back.
Concentrate More On Heplisav-BDynavax announced that the restructuring process will involve trying to find out alternative ...
Read The Full Article On MicroSmallCap.com
Get early insight on hidden secret gems on MicroSmallCap. Follow Crypto, Mining, Cannabis and Energy stocks and get free research reports here.
All content provided by MicroSmallCap is subject to our Terms Of Use and Disclaimer.